Cognitive function in postmenopausal women treated with raloxifene

New England Journal of Medicine

Volumn 344, Issue 16, 2001, Pages 1207-1213

  Yaffe, Kristine ^a,b   Krueger, Kathyrn ^c   Sarkar, Somnath ^c   Grady, Deborah ^b   Barrett Connor, Elizabeth ^d   Cox, Davida ^c   Nickelsen, Thomas ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RALOXIFENE;

ADULT; AGED; ARTICLE; ATTENTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; VERBAL MEMORY;

AGED; COGNITION; COGNITION DISORDERS; FEMALE; HOT FLASHES; HUMANS; MEMORY; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 0035912147     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200104193441604     Document Type: Article

References (31)

1. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system
2. Ovarian steroids and the brain: Implications for cognition and aging
3. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
4. Estrogen use and verbal memory in healthy postmenopausal women
5. Estrogen replacement therapy and longitudinal decline in visual memory: A possible protective effect?
6. An evaluation of psychologic effects of sex hormone administration in aged women. I. Results of therapy after six months
7. Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory
8. Oestrogen therapy and the menopausal syndrome
9. The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women
10. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women
11. Estrogen improves psychological function in asymptomatic postmenopausal women
12. Effects of estrogen on memory function in surgically menopausal women
13. The effect of short-term estrogen replacement therapy on cognition: A randomized, double-blind, cross-over trial in postmenopausal women
14. Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: Verbal memory changes are associated with the treatment induced estradiol levels
15. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks
16. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
17. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
18. Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells
19. Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats
20. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats
21. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
22. Hormones and the aging brain
23. Geriatric depression scale: Recent evidence and development of a shorter version
24. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer's disease
25. Validation of a short orientation-memory-concentration test of cognitive impairment
26. Validity of the trail making test as an indicator of organic brain damage
27. The set test as an aid to the detection of dementia in old people
28. Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: The MoVIES project
29. Methodological issues in the study of cognitive decline
30. Raloxifene hydrochloride, a selective estrogen receptor modulator: Safety assessment of effects on cognitive function and mood in postmenopausal women
31. Climacteric symptoms do not impair cognitive performances in postmenopause